Search hospitals
>
Alabama
>
Birmingham
University of Alabama at Birmingham Cancer Center
Claim this profile
Birmingham, Alabama 35233
Global Leader in Brain Tumor
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for Ovarian Cancer
663 reported clinical trials
37 medical researchers
Summary
University of Alabama at Birmingham Cancer Center is a medical facility located in Birmingham, Alabama. This center is recognized for care of Brain Tumor, Breast Cancer, Lung Cancer, Cancer, Ovarian Cancer and other specialties. University of Alabama at Birmingham Cancer Center is involved with conducting 663 clinical trials across 592 conditions. There are 37 research doctors associated with this hospital, such as Victor T. Lin, Rebecca C. Arend, Amitkumar Mehta, MD, and Pankit Vachhani.
Area of expertise
Brain Tumor
University of Alabama at Birmingham Cancer Center has run 74 trials for Brain Tumor. Some of their research focus areas include:
Breast Cancer
University of Alabama at Birmingham Cancer Center has run 65 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Victor T. Lin
Mary Bird Perkins Cancer Center
1 year of reported clinical research
Rebecca C. Arend
University of Alabama at Birmingham Cancer Center
2 years of reported clinical research
Amitkumar Mehta, MD
University of Alabama at Birmingham
13 years of reported clinical research
Pankit Vachhani
University of Alabama at Birmingham
4 years of reported clinical research
Clinical Trials running at University of Alabama at Birmingham Cancer Center
Ovarian Cancer
Esophageal cancer
Skin Cancer
Cancer
Breast Cancer
Lung Cancer
Bladder Cancer
Cervical Cancer
Breast cancer
Kidney Cancer
Olaparib +/- Bevacizumab
for Ovarian Cancer
This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer. Olaparib is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme inhibitor and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving olaparib for one year with or without bevacizumab may be effective in treating patients with BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer, when compared to two years of olaparib.
Recruiting
2 awards
Phase 3
4 criteria
Neratinib or Neratinib + Palbociclib
for Cancer
This phase II ComboMATCH treatment trial compares the effect of neratinib to the combination of neratinib and palbociclib in treating patients with HER2 positive solid tumors. Neratinib and palbociclib are in a class of medications called kinase inhibitors. They work by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of tumor cells. Giving neratinib and palbociclib in combination may shrink or stabilize cancers that over-express a specific biomarker called HER2.
Recruiting
1 award
Phase 2
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting
1 award
Phase 2
17 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Alabama at Birmingham Cancer Center?
University of Alabama at Birmingham Cancer Center is a medical facility located in Birmingham, Alabama. This center is recognized for care of Brain Tumor, Breast Cancer, Lung Cancer, Cancer, Ovarian Cancer and other specialties. University of Alabama at Birmingham Cancer Center is involved with conducting 663 clinical trials across 592 conditions. There are 37 research doctors associated with this hospital, such as Victor T. Lin, Rebecca C. Arend, Amitkumar Mehta, MD, and Pankit Vachhani.
Where is University of Alabama at Birmingham Cancer Center located?
The UAB Comprehensive Cancer Center is situated at 1824 6th Ave S, Birmingham, AL 35233. For appointments at the UAB Women & Infants Center and Hazelrig-Salter Radiation Oncology Center, valet parking is offered at the entrance, with an alternative to self-park in the deck located at 4th Avenue and 18th Street South. The main parking deck for patients and guests attending UAB Hospital is also at 4th Avenue and 18th Street South.
Who should I call to ask about financial aid or insurance network?
For financial assistance at the University of Alabama at Birmingham (UAB) Cancer Center, contact UAB Medicine Patient Billing Solutions at (205) 934-6400 or toll-free at (888) 309-8435. For insurance inquiries, call the main switchboard at (205) 934-4011. Hearing-impaired individuals can reach out via the TDD line at (205) 934-4642.
What insurance does University of Alabama at Birmingham Cancer Center accept?
The University of Alabama at Birmingham Cancer Center accepts various insurance plans, including Blue Cross and Blue Shield of Alabama, Viva Health, and Blue Cross/Blue Shield. Accepted plans include Viva UAB, Viva Access, and Blue Cross/Blue Shield's nationwide PPO network, covering one annual eye exam and offering student and sabbatical riders for out-of-network services. Additionally, the University of Alabama at Birmingham National Alumni Society offers life, health, travel, and other insurance plans for alumni and their families.
What awards or recognition has University of Alabama at Birmingham Cancer Center received?
The University of Alabama at Birmingham Comprehensive Cancer Center is the only National Cancer Institute-designated comprehensive cancer center in a six-state area, serving Alabama, Arkansas, Georgia, Louisiana, Mississippi, and South Carolina. It is renowned for its excellence in cancer research and patient care, earning rankings among the top institutions in the Southeast and the nation by U.S. News. Additionally, it has been recognized as a Magnet-designated organization by the American Nurses Credentialing Center Magnet Recognition Program® for the fifth consecutive time and named a Health Care Equality Leader by the Human Rights Campaign Foundation.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.